Palo Alto, CA, United States of America

Hye-Ryeon Lee

This inventor holds 1 USPTO granted patent. Top assignee: Imprimed, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hye-Ryeon Lee. Retrieved from https://idiyas.com/inventor/hye-ryeon-lee-dc70gnhl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hye-Ryeon Lee: Innovator in High-Throughput Screening Technologies

Introduction

Hye-Ryeon Lee is a prominent inventor based in Palo Alto, CA. He has made significant contributions to the field of pharmaceutical sciences through his innovative inventions. His work focuses on developing advanced methods for high-throughput screening of chemical and biochemical compounds.

Latest Patents

Hye-Ryeon Lee holds 1 patent for his invention titled "Devices and methods for high-throughput screening of chemical and biochemical compounds." This patent describes an article of manufacture that includes an array of distinct and separate regions, each containing respective pharmaceutical compounds. The design features multiple regions, allowing for the testing of various sets of pharmaceutical compounds in a systematic manner.

Career Highlights

Throughout his career, Hye-Ryeon Lee has been associated with Imprimed, Inc., where he has played a crucial role in advancing research and development in pharmaceutical technologies. His expertise in high-throughput screening has positioned him as a valuable asset in the industry.

Collaborations

Hye-Ryeon Lee has collaborated with notable colleagues, including Sungwon Lim and Jun Kim. These partnerships have fostered innovation and contributed to the success of their projects.

Conclusion

Hye-Ryeon Lee's contributions to high-throughput screening technologies exemplify his commitment to advancing pharmaceutical research. His innovative patent and collaborations highlight his role as a key figure in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…